ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $382,198 | -32.4% | 14,224 | -10.3% | 0.01% | -33.3% |
Q2 2023 | $565,211 | +40.5% | 15,850 | +0.1% | 0.02% | +31.2% |
Q1 2023 | $402,336 | +64584.2% | 15,840 | +3.4% | 0.02% | -38.5% |
Q4 2022 | $622 | -99.8% | 15,324 | +87.6% | 0.03% | +116.7% |
Q3 2022 | $270,000 | – | 8,167 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |